Potential Alzheimer’s Treatments Moving Ahead and Breakthroughs Likely, Scientists Say

Potential Alzheimer’s Treatments Moving Ahead and Breakthroughs Likely, Scientists Say
The Alzheimer’s disease community has grown accustomed to news of an endless string of failures in clinical trials of potential treatments. In fact, only four such treatments went on to win approval between 1998 and 2014 — addressing symptoms but not altering the relentless course of the disease. PhRMA — a group of major U.S. pharmaceutical companies — recently released a list of treatments currently in clinical development for Alzheimer’s, along with a “Medicines in Development 2017 Update” to reassure patients and caregivers that all these failed trials have advanced disease understanding, and that this is reflected in new efforts. But what does this
Subscribe or to access all post and page content.